163. The ID Specialist and the Opioid Epidemic: What You Need to Know Now
Friday, October 5, 2018: 2:00 PM-3:15 PM
Room: W 2005-2024

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • review strategies for successful treatment of chronic HCV among IDU in the context of elimination of HCV as a public health problem
  • explain the key elements of a clinical practice-based model for delivering medication-assisted treatment for opiate use disorder by infectious disease specialists
  • discuss the evidence base for supervised injection facilities for persons who inject drugs, including preventing infectious complications of IDU

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Hospital administrators, Hospital epidemiologists, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Members-in-training, Nurses, Pharmacists, Public health practitioners

Tracks: Trainee, Pediatric ID, HIV-STD-TB, Epidemiology and Infection Control, Adult ID

Moderators:  Jeffrey Duchin, MD, FIDSA, Public Hlth Seattle & King Cnty and John Ward, MD, Task Force for Global Health

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-242-L01-P


J. Duchin, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.